4QKX
Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody
4QKX の概要
| エントリーDOI | 10.2210/pdb4qkx/pdb |
| 分子名称 | Beta-2 adrenergic receptor, R9 protein, SODIUM ION, ... (4 entities in total) |
| 機能のキーワード | 7-transmembrane helices, signal transduction, g proteins, membrane, membrane protein-immune system complex, membrane protein/immune system |
| 由来する生物種 | Enterobacteria phage T4 詳細 |
| 細胞内の位置 | Cell membrane ; Multi- pass membrane protein : P07550 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 66810.86 |
| 構造登録者 | Weichert, D.,Kruse, A.C.,Manglik, A.,Hiller, C.,Zhang, C.,Huebner, H.,Kobilka, B.K.,Gmeiner, P. (登録日: 2014-06-10, 公開日: 2014-07-23, 最終更新日: 2024-11-20) |
| 主引用文献 | Weichert, D.,Kruse, A.C.,Manglik, A.,Hiller, C.,Zhang, C.,Hubner, H.,Kobilka, B.K.,Gmeiner, P. Covalent agonists for studying G protein-coupled receptor activation. Proc.Natl.Acad.Sci.USA, 111:10744-10748, 2014 Cited by PubMed Abstract: Structural studies on G protein-coupled receptors (GPCRs) provide important insights into the architecture and function of these important drug targets. However, the crystallization of GPCRs in active states is particularly challenging, requiring the formation of stable and conformationally homogeneous ligand-receptor complexes. Native hormones, neurotransmitters, and synthetic agonists that bind with low affinity are ineffective at stabilizing an active state for crystallogenesis. To promote structural studies on the pharmacologically highly relevant class of aminergic GPCRs, we here present the development of covalently binding molecular tools activating Gs-, Gi-, and Gq-coupled receptors. The covalent agonists are derived from the monoamine neurotransmitters noradrenaline, dopamine, serotonin, and histamine, and they were accessed using a general and versatile synthetic strategy. We demonstrate that the tool compounds presented herein display an efficient covalent binding mode and that the respective covalent ligand-receptor complexes activate G proteins comparable to the natural neurotransmitters. A crystal structure of the β2-adrenoreceptor in complex with a covalent noradrenaline analog and a conformationally selective antibody (nanobody) verified that these agonists can be used to facilitate crystallogenesis. PubMed: 25006259DOI: 10.1073/pnas.1410415111 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






